v3.26.1
Condensed Consolidated Income Statements (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue $ 2,336 $ 2,301 $ 4,461 $ 4,370
Cost of revenue 1,373 1,409 2,695 2,710
Gross profit 963 892 1,766 1,660
Selling, general and administrative expenses 503 503 975 963
Research and development expenses 59 58 115 114
Restructuring and asset impairment charges 11 26 42 47
Operating income 390 305 634 536
Interest expense (7) (9) (11) (17)
Other non-operating (expense)/income, net (3) 3 (3) 7
Loss on sale of businesses (16) 0 (12) (10)
Income before taxes 364 299 608 516
Income tax expense (103) (75) (158) (125)
Net income 261 224 450 391
Net loss attributable to non-controlling interests 2 2 6 4
Net income attributable to Xylem $ 263 $ 226 $ 456 $ 395
Earnings per share:        
Basic (usd per share) $ 1.11 $ 0.93 $ 1.90 $ 1.62
Diluted (usd per share) $ 1.11 $ 0.93 $ 1.90 $ 1.62
Weighted average number of shares:        
Basic (in shares) 236,295 243,397 239,534 243,251
Diluted (in shares) 236,574 243,859 239,967 243,820
Revenue from products        
Revenue $ 1,953 $ 1,911 $ 3,710 $ 3,620
Cost of revenue 1,093 1,129 2,150 2,170
Revenue from services        
Revenue 383 390 751 750
Cost of revenue $ 280 $ 280 $ 545 $ 540